Legal Disclaimer

Forward-looking statements.

This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on current expectations and assumptions as of the date of this publication. PharmatrophiX undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

Investigational, not approved.

LM11A-31 and other compounds discussed on this website are investigational drugs. Their uses have not been approved by the U.S. Food and Drug Administration or other health authorities. There is no guarantee that these investigational drugs will receive regulatory approval. Nothing on this website should be construed as promoting or advertising any investigational product or as suggesting that any investigational product is safe or effective for any use.

Not a securities offer.

This website does not constitute an offer to sell or a solicitation of an offer to buy securities. Any such offer or solicitation will be made only by means of appropriate offering documents and only in jurisdictions where permitted by law.

Not medical advice.

The information on this website is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for medical advice regarding any health condition.

Limitation of liability.

To the fullest extent permitted by applicable law, PharmatrophiX makes no warranties regarding the accuracy, completeness, or reliability of any information on this website. We shall not be liable for any damages arising from the use of this website.